| S.No. | Title | Funding Agency |
| 1 | Spiral Dx: Tremor diagnosis and quantification using artificial intelligence | DBT |
| 2 | Molecular analysis of Neurodegeneration with Brain Iron Accumulation (NBIA) disorders | ICMR |
| 3 | Genetic Architecture of Parkinson’s disease in India | Michael J Fox Foundation, USA |
| 4 | Spectrum of Genetic mutations and their association with clinical Phenotypes of Progressive Supranuclear Palsy | ICMR |
| 5 | Investigating the effects of age of onset on the structural connectome in essential tremor through High Angular Resolution Diffusion MRI | DBT |
| 6 | Advanced Network Analysis of the Structural Connectome of human brain | DST-SERB |
| 7 | Susceptibility of brain white matter to inflammatory mediators in Parkinson’s disease: An exploratory DTI study | DST-SERB |
| 8 | Next generation sequencing to investigate mitochondrial mutation spectrum in movement disorders | DST-SERB |
| 9 | The Indian Movement Disorder Registry and Biobank: Clinical and genetic evaluation of movement disorders in Indian patients | DBT |
| 10 | Characterization and functional validation of Huntington’s disease modifiers influencing disease progression and manifestation : a cross-species approach | DST-SERB |
| 11 | Generation of induced pluripotent stem cells and midbrain floor plate cells from Indian ethnicity Parkinson’s disease patients | PACE scheme of BIRAC |
| 12 | Effect of deep brain stimulation on speech of patients with Parkinson’s Disease | NIMHANS |
| 13 | A multicentre, randomized, double blind, placebo-controlled trial to evaluate the effects of intra erythrocyte dexamethasone sodium phosphate on neurological symptoms in patients with ataxia telangiectasia | ERYDEL SpA |
| 14 | Can cortical excitability changes predict the onset of cognitive impairment in Parkinson’s disease? | DST-CSRI |
| 15 | Protein biomarker discovery for Parkinson’s disease | Wellcome Trust-DBT India Alliance |
| 16 | Circulating microRNAs as biomarkers to differentiate between Parkinson’s Disease, Multiple System Atrophy-Parkinsonism, and Progressive Supranuclear Palsy | ICMR |
| 17 | Identification and validation of biomarkers for Parkinsonian syndromes with cognitive impairment | ICMR |
| 18 | Genetic, Proteomic and Advanced Neuroimaging correlates of Spinocerebellar ataxia 2 | NIMHANS |
| 19 | Identification of biomarkers for psychosis in Parkinson’s disease by retinal imaging, genetic polymorphism studies and neuropsychological profiling | NIMHANS |
| 20 | Assessment of Brain Plasticity Induced by Repeated Transcranial Magnetic Stimulation in Patient with Movement Disorder Using Resting Brain Networks and Connectivity | DST |
| 21 | Exploring subclinical cerebellar dysfunction in patients with essential tremor, primary writing tremor and writer’s cramp by quantitative characterization of ocular movements and eye-hand coordination and advanced neuroimaging techniques. | DBT |
| 22 | Gray and white matter correlates of REM Sleep Behaviour Disorder and psychosis in Parkinson’s Disease | ICMR |
| 23 | Role of Metals in the Etiopathogenesis of Parkinson’s Disease | DBT |
| 24 | Glucocerebrosidase mutation in Parkinson’s Disease | DBT |
| 25 | Genetics of movement disorders: Genotype-phenotype correlates in ataxias and Huntington’s disease | ICMR |
| 26 | Genotypic-phenotypic correlation of Spinocerebellar Ataxias | ICMR |
Completed Projects
Proudly Powered By Novelty-Data Solutions LLP. www.novelty-data.com